Incorporating Innovative Techniques Toward Extrapolation and Efficient Pediatric Drug Development
The conduct of pediatric clinical trials is legally required, monitored, and encouraged in major geographic areas such as the United States and Europe. However, because pediatric patients are considered vulnerable populations, they should only be enrolled as research subjects in a clinical trial if...
Saved in:
| Published in | Therapeutic innovation & regulatory science Vol. 53; no. 5; pp. 567 - 578 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Los Angeles, CA
SAGE Publications
01.09.2019
Springer International Publishing Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The conduct of pediatric clinical trials is legally required, monitored, and encouraged in major geographic areas such as the United States and Europe. However, because pediatric patients are considered vulnerable populations, they should only be enrolled as research subjects in a clinical trial if enrolling adult subjects will not be able to answer the scientific question related to the health and welfare of children. Thus, there is an ethical obligation to build the foundation for the use of pediatric extrapolation and related innovative analytical strategies with appropriately designed pediatric and adult clinical trials to reduce the amount of, or general need for, additional information needed from children to reach conclusions. This manuscript discusses innovative applications of clinical trial designs, analytic strategies to more efficiently leverage prior information, and modeling approaches that impact the data required to determine efficacy of an investigational drug in pediatrics. The planning of pediatric trials and regulatory interactions related to required pediatric studies and the expectations for innovative analytics are also discussed. |
|---|---|
| AbstractList | The conduct of pediatric clinical trials is legally required, monitored, and encouraged in major geographic areas such as the United States and Europe. However, because pediatric patients are considered vulnerable populations, they should only be enrolled as research subjects in a clinical trial if enrolling adult subjects will not be able to answer the scientific question related to the health and welfare of children. Thus, there is an ethical obligation to build the foundation for the use of pediatric extrapolation and related innovative analytical strategies with appropriately designed pediatric and adult clinical trials to reduce the amount of, or general need for, additional information needed from children to reach conclusions. This manuscript discusses innovative applications of clinical trial designs, analytic strategies to more efficiently leverage prior information, and modeling approaches that impact the data required to determine efficacy of an investigational drug in pediatrics. The planning of pediatric trials and regulatory interactions related to required pediatric studies and the expectations for innovative analytics are also discussed.The conduct of pediatric clinical trials is legally required, monitored, and encouraged in major geographic areas such as the United States and Europe. However, because pediatric patients are considered vulnerable populations, they should only be enrolled as research subjects in a clinical trial if enrolling adult subjects will not be able to answer the scientific question related to the health and welfare of children. Thus, there is an ethical obligation to build the foundation for the use of pediatric extrapolation and related innovative analytical strategies with appropriately designed pediatric and adult clinical trials to reduce the amount of, or general need for, additional information needed from children to reach conclusions. This manuscript discusses innovative applications of clinical trial designs, analytic strategies to more efficiently leverage prior information, and modeling approaches that impact the data required to determine efficacy of an investigational drug in pediatrics. The planning of pediatric trials and regulatory interactions related to required pediatric studies and the expectations for innovative analytics are also discussed. The conduct of pediatric clinical trials is legally required, monitored, and encouraged in major geographic areas such as the United States and Europe. However, because pediatric patients are considered vulnerable populations, they should only be enrolled as research subjects in a clinical trial if enrolling adult subjects will not be able to answer the scientific question related to the health and welfare of children. Thus, there is an ethical obligation to build the foundation for the use of pediatric extrapolation and related innovative analytical strategies with appropriately designed pediatric and adult clinical trials to reduce the amount of, or general need for, additional information needed from children to reach conclusions. This manuscript discusses innovative applications of clinical trial designs, analytic strategies to more efficiently leverage prior information, and modeling approaches that impact the data required to determine efficacy of an investigational drug in pediatrics. The planning of pediatric trials and regulatory interactions related to required pediatric studies and the expectations for innovative analytics are also discussed. |
| Author | Hampson, Lisa Weber, Sebastian Portman, Ronald Kordy, Kattayoun Gamalo-Siebers, Margaret Nelson, Robert M. |
| Author_xml | – sequence: 1 givenname: Margaret orcidid: 0000-0003-2428-3298 surname: Gamalo-Siebers fullname: Gamalo-Siebers, Margaret – sequence: 2 givenname: Lisa surname: Hampson fullname: Hampson, Lisa – sequence: 3 givenname: Kattayoun surname: Kordy fullname: Kordy, Kattayoun – sequence: 4 givenname: Sebastian surname: Weber fullname: Weber, Sebastian – sequence: 5 givenname: Robert M. surname: Nelson fullname: Nelson, Robert M. – sequence: 6 givenname: Ronald surname: Portman fullname: Portman, Ronald |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31084211$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkU1P3DAQQK0KVD7KnVMViUsvAY_j2M4RAS0rIcFhe468zngxytqpnWzbf19vd6HSHlB98WjmPXs0c0IOfPBIyDnQSwAprxgIxWVDoVGc1Rw-kONNquSK8oPXONePyFlKLzSfRtWSqY_kqAKaHYBjomfehDiEqEfnl8XM-7DO4RqLOZpn735MmIp5-KljV9z9GqMeQp_rwRfa54y1zjj0Y_GEndNjdKa4jdOyuMU19mFY5dIncmh1n_Bsd5-S71_v5jf35cPjt9nN9UNpOJVjaWsLQi7AUtRcIzImq05JjpSDEqaznRHWUF4rSg3vNMdFBVwZ2dRCadVUp-TL9t0hhk3XY7tyyWDfa49hSi1jFaPARAMZvdhDX8IUfe4uU7JhopKNyNTnHTUtVti1Q3QrHX-3r8PLAN0CJoaUIto3BGi7WVG7v6KsiD3FuPHvPPNoXf-eCFsx5T_8EuO_lt9xyp2jl_gf_B8dT68L |
| CitedBy_id | crossref_primary_10_1007_s43441_021_00367_9 crossref_primary_10_1080_10543406_2023_2170405 crossref_primary_10_1080_15265161_2020_1730489 crossref_primary_10_1002_cpt_1723 crossref_primary_10_1080_10543406_2022_2089159 crossref_primary_10_1080_10543406_2022_2162069 crossref_primary_10_1177_2168479019869754 crossref_primary_10_1002_ppul_26882 crossref_primary_10_1080_10543406_2020_1821704 |
| Cites_doi | 10.1371/journal.pmed.1002520 10.1177/1740774509356002 10.2307/2531628 10.1111/j.1541-0420.2007.00888.x 10.1093/biomet/79.3.593 10.1002/pst.1807 10.1111/bcp.12402 10.1007/s40265-017-0771-8 10.1002/sim.5553 10.1542/peds.2010-3487 10.3899/jrheum.100632 10.1542/peds.104.S3.585 10.1158/1078-0432.CCR-15-0612 10.1056/NEJMsb1609216 10.14694/EdBook_AM.2015.35.e141 10.1542/peds.2013-2987 10.1111/biom.12242 10.1001/jamapediatrics.2013.465 10.1214/17-AOAS1122 10.1002/cncr.24286 10.1542/peds.2016-0223 10.1002/pst.1879 10.3899/jrheum.110765 10.1002/pst.1589 10.1136/medethics-2016-103600 10.1007/978-3-642-20195-0_11 10.1002/0470033312 10.1017/CBO9780511803161 10.1111/j.1467-985X.2008.00547.x 10.1177/2168479017696265 10.1177/2168479018764650 10.1080/10543406.2016.1226327 10.1200/JCO.2010.28.4687 10.1002/sim.6865 10.1111/j.1541-0420.2005.00344.x |
| ContentType | Journal Article |
| Copyright | The Author(s) 2019 Drug Information Association, Inc 2019 |
| Copyright_xml | – notice: The Author(s) 2019 – notice: Drug Information Association, Inc 2019 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7U7 C1K K9. NAPCQ 7X8 |
| DOI | 10.1177/2168479019842541 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 2168-4804 |
| EndPage | 578 |
| ExternalDocumentID | 31084211 10_1177_2168479019842541 10.1177_2168479019842541 |
| Genre | Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | 01A 0R~ 2JY 406 53G 7RV 7X7 88I 8AF 8AO 8FE 8FH 8FI 8FJ 8FW 8G5 AACDK AAHNG AAJBT AARDL AASML AATNV AAUYE ABAKF ABAWP ABBRH ABCCA ABDBE ABECU ABFSG ABFTV ABJNI ABKCH ABMQK ABTEG ABTKH ABUWG ACAOD ACDTI ACDXX ACGFS ACGOD ACHSB ACPRK ACSTC ACZOJ ADBBV ADTPH ADYFF AEFQL AEMSY AENEX AERKM AESKC AEUHG AEWDL AEZWR AFBBN AFDZB AFHIU AFKRA AFOHR AFQWF AFRAH AGMZJ AGQEE AHMBA AHPBZ AHWEU AIGIU AILAN AIXLP AJZVZ ALIPV ALMA_UNASSIGNED_HOLDINGS AMXSW AMYLF ARTOV ATHPR AUTPY AYAKG AYFIA AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKOMP BPHCQ BVXVI CCPQU DPUIP DWQXO EBLON EBS EJD EX3 FIGPU FNLPD FYUFA GNUQQ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GUQSH H13 HCIFZ HF~ HMCUK HZ~ IKXTQ IWAJR J8X JZLTJ K.F KOV LK8 LLZTM M2O M2P M2Q M7P NAPCQ NPVJJ NQJWS O9- P.B PHGZM PHGZT PQQKQ PROAC PT4 ROL RSV S01 S0X SAUOL SCNPE SFC SJFOW SJYHP SNE SNPRN SOHCF SOJ SRMVM SSLCW UKHRP WOW ZCA -MK 3V. AADTT ABQXT ACLZU ACSBE ACTQU ACUIR AEUIJ AJMMQ DD0 DF. DH~ DV7 AAYXX CITATION CGR CUY CVF ECM EIF NPM --- 29G 5GY 7U7 8R4 8R5 BES C1K E3Z F5P K9. P2P PRG Q2X SJN TAE VQ3 7X8 |
| ID | FETCH-LOGICAL-c407t-f5f167b1f0ea4aee2273d874e04186cdfdc6fc045800c4da4eb3148c79568a893 |
| ISSN | 2168-4790 2168-4804 |
| IngestDate | Fri Jul 11 10:04:41 EDT 2025 Mon Jun 30 10:59:30 EDT 2025 Wed Feb 19 02:30:44 EST 2025 Tue Jul 01 02:47:53 EDT 2025 Thu Apr 24 23:03:57 EDT 2025 Fri Feb 21 02:40:18 EST 2025 Tue Jun 17 22:29:51 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | pediatric trials extrapolation hierarchical model Bayesian methods matching |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c407t-f5f167b1f0ea4aee2273d874e04186cdfdc6fc045800c4da4eb3148c79568a893 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-2428-3298 |
| PMID | 31084211 |
| PQID | 2279263796 |
| PQPubID | 30058 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_2232012691 proquest_journals_2279263796 pubmed_primary_31084211 crossref_primary_10_1177_2168479019842541 crossref_citationtrail_10_1177_2168479019842541 springer_journals_10_1177_2168479019842541 sage_journals_10_1177_2168479019842541 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20190900 2019-9-00 2019-09-00 20190901 |
| PublicationDateYYYYMMDD | 2019-09-01 |
| PublicationDate_xml | – month: 9 year: 2019 text: 20190900 |
| PublicationDecade | 2010 |
| PublicationPlace | Los Angeles, CA |
| PublicationPlace_xml | – name: Los Angeles, CA – name: Cham – name: Switzerland – name: Thousand Oaks |
| PublicationTitle | Therapeutic innovation & regulatory science |
| PublicationTitleAbbrev | Ther Innov Regul Sci |
| PublicationTitleAlternate | Ther Innov Regul Sci |
| PublicationYear | 2019 |
| Publisher | SAGE Publications Springer International Publishing Springer Nature B.V |
| Publisher_xml | – name: SAGE Publications – name: Springer International Publishing – name: Springer Nature B.V |
| References | Lin, Gamalo-Siebers, Tiwari 2018; 17 Wilson 1999; 104 Hlavin, Koenig, Male 2016; 35 Przepiorka, Ko, Deisseroth 2015; 21 Momper, Mulugeta, Green 2013; 167 Johnson, Granton, Tomlinson 2011; 38 Markham 2017; 77 Savic, Basu 2017; 16 Fouladi, Stewart, Blaney 2010; 28 2002 Hume, Lewis, Nelson 2017; 43 Mandrekar, Dahlberg, Simon 2015 Gamalo-Siebers, Tiwari, LaVange 2016; 26 Franson, Kinnett, Cripe 2019; 53 Johnson, Granton, Tomlinson 2012; 39 Neuenschwander, Capkun-Niggli, Branson 2010; 7 Kovalchik, Varadhan, Fetterman 2013; 32 2003; 108 Schmidli, Gsteiger, Roychoudhury 2014; 70 Sherman, Anderson, Dal Pan 2016; 375 Dunne, Rodriguez, Murphy 2011; 128 Penkov, Tomasi, Eichler 2017; 51 Hwang, Tomasi, Bourgeois 2018; 15 Turner, Spiegelhalter, Smith, Thompson 2009; 172 Bretz, Pinheiro, Branson 2005; 61 Pica, Bourgeois 2016; 138 Viele, Berry, Neuenschwander 2014; 13 Malec, Sedransk 1992; 79 Morita, Thall, Müller 2008; 64 Hampson, Herold, Posch 2014; 78 Weber, Gelman, Lee 2018; 12 O’Quigley, Pepe, Fisher 1990; 46 Loeb, Garrett-Mayer, Hobbs 2009; 115 Wharton, Murphy, Avant 2014; 134 Wharton, Murphy, Avant (CR15) 2014; 134 Przepiorka, Ko, Deisseroth (CR56) 2015; 21 Penkov, Tomasi, Eichler (CR9) 2017; 51 Hampson, Herold, Posch (CR41) 2014; 78 Pica, Bourgeois (CR14) 2016; 138 Viele, Berry, Neuenschwander (CR32) 2014; 13 Roth-Cline, Gerson, Bright, Seyberth, Rane, Schwab (CR18) 2011 Neuenschwander, Capkun-Niggli, Branson (CR33) 2010; 7 Dunne, Rodriguez, Murphy (CR19) 2011; 128 Morita, Thall, Müller (CR36) 2008; 64 Gamalo-Siebers, Savic, Basu (CR31) 2017; 16 Markham (CR54) 2017; 77 Momper, Mulugeta, Green (CR57) 2013; 167 Malec, Sedransk (CR37) 1992; 79 Turner, Spiegelhalter, Smith, Thompson (CR23) 2009; 172 CR3 CR6 CR5 CR8 Pearl (CR53) 2009 CR7 Behrman, Field (CR4) 2004 CR47 CR46 CR45 Johnson, Granton, Tomlinson (CR43) 2012; 39 CR40 Bretz, Pinheiro, Branson (CR29) 2005; 61 Gamalo-Siebers, Tiwari, La Vange (CR49) 2016; 26 Hwang, Tomasi, Bourgeois (CR13) 2018; 15 Kovalchik, Varadhan, Fetterman (CR48) 2013; 32 Hlavin, Koenig, Male (CR44) 2016; 35 Sherman, Anderson, Dal Pan (CR50) 2016; 375 Loeb, Garrett-Mayer, Hobbs (CR27) 2009; 115 Schmidli, Gsteiger, Roychoudhury (CR35) 2014; 70 Wilson, Morselli (CR1) 1975 CR17 CR12 O’Hagan, Buck, Daneshkhah (CR39) 2006 CR11 CR55 CR10 Fouladi, Stewart, Blaney (CR28) 2010; 28 CR52 CR51 O’Quigley, Pepe, Fisher (CR26) 1990; 46 Hume, Lewis, Nelson (CR30) 2017; 43 Weber, Gelman, Lee (CR34) 2018; 12 Johnson, Granton, Tomlinson (CR42) 2011; 38 Lin, Gamalo-Siebers, Tiwari (CR38) 2018; 17 CR25 CR24 CR22 CR21 CR20 Wilson (CR2) 1999; 104 Franson, Kinnett, Cripe (CR16) 2019; 53 S Weber (5305567_CR34) 2018; 12 D Malec (5305567_CR37) 1992; 79 JD Momper (5305567_CR57) 2013; 167 M Roth-Cline (5305567_CR18) 2011 SR Johnson (5305567_CR43) 2012; 39 J Lin (5305567_CR38) 2018; 17 H Schmidli (5305567_CR35) 2014; 70 5305567_CR47 5305567_CR45 N Pica (5305567_CR14) 2016; 138 5305567_CR46 R Turner (5305567_CR23) 2009; 172 5305567_CR40 K Viele (5305567_CR32) 2014; 13 (5305567_CR4) 2004 J O’Quigley (5305567_CR26) 1990; 46 J Dunne (5305567_CR19) 2011; 128 J Pearl (5305567_CR53) 2009 D Penkov (5305567_CR9) 2017; 51 M Gamalo-Siebers (5305567_CR31) 2017; 16 LV Hampson (5305567_CR41) 2014; 78 SA Kovalchik (5305567_CR48) 2013; 32 JT Wilson (5305567_CR2) 1999; 104 M Fouladi (5305567_CR28) 2010; 28 SR Johnson (5305567_CR42) 2011; 38 M Hume (5305567_CR30) 2017; 43 5305567_CR17 5305567_CR21 5305567_CR22 5305567_CR20 5305567_CR25 TJ Hwang (5305567_CR13) 2018; 15 5305567_CR24 JT Wilson (5305567_CR1) 1975 M Gamalo-Siebers (5305567_CR49) 2016; 26 T Franson (5305567_CR16) 2019; 53 5305567_CR3 GT Wharton (5305567_CR15) 2014; 134 DM Loeb (5305567_CR27) 2009; 115 5305567_CR5 5305567_CR6 5305567_CR7 5305567_CR8 A Markham (5305567_CR54) 2017; 77 5305567_CR10 5305567_CR11 5305567_CR55 D Przepiorka (5305567_CR56) 2015; 21 5305567_CR52 G Hlavin (5305567_CR44) 2016; 35 F Bretz (5305567_CR29) 2005; 61 B Neuenschwander (5305567_CR33) 2010; 7 5305567_CR12 RE Sherman (5305567_CR50) 2016; 375 5305567_CR51 S Morita (5305567_CR36) 2008; 64 A O’Hagan (5305567_CR39) 2006 |
| References_xml | – volume: 38 start-page: 462 issue: 3 year: 2011 end-page: 469 article-title: Effect of warfarin on survival in scleroderma-associated pulmonary arterial hypertension (SSc-PAH) and idiopathic PAH. Belief elicitation for Bayesian priors publication-title: J Rheumatol – volume: 79 start-page: 593 issue: 3 year: 1992 end-page: 601 article-title: Bayesian methodology for combining the results from different experiments when the specifications for pooling are uncertain publication-title: Biometrika – volume: 172 start-page: 21 year: 2009 end-page: 47 article-title: Bias modelling in evidence synthesis publication-title: J R Stat Soc Ser A Stat Soc – volume: 46 start-page: 33 issue: 1 year: 1990 end-page: 48 article-title: Continual reassessment method: a practical design for phase 1 clinical trials in cancer publication-title: Biometrics – volume: 108 start-page: 117 issue: 155 year: 2003 article-title: Pediatric Research Equity Act of 2003 publication-title: Public Law – volume: 12 start-page: 1583 issue: 3 year: 2018 end-page: 1604 article-title: Bayesian aggregation of average data: an application in drug development publication-title: Ann Appl Stat – start-page: 107 year: 2002 end-page: 109 article-title: Best Pharmaceuticals for Children Act publication-title: Public Law – volume: 78 start-page: 898 issue: 4 year: 2014 end-page: 907 article-title: Bridging the gap: a review of dose investigations in paediatric investigation plans publication-title: Br J Clin Pharmacol – volume: 134 start-page: e512 issue: 2 year: 2014 end-page: e518 article-title: Impact of pediatric exclusivity on drug labeling and demonstrations of efficacy publication-title: Pediatrics – volume: 77 start-page: 1247 year: 2017 end-page: 1249 article-title: Cerliponase alfa: first global approval publication-title: Drugs – volume: 13 start-page: 41 issue: 1 year: 2014 end-page: 54 article-title: Use of historical control data for assessing treatment effects in clinical trials publication-title: Pharm Stat – volume: 16 start-page: 232 issue: 4 year: 2017 end-page: 249 article-title: Statistical modeling for Bayesian extrapolation of adult clinical trial information in pediatric drug evaluation publication-title: Pharm Stat – volume: 26 start-page: 1040 issue: 6 year: 2016 end-page: 1055 article-title: Flexible shrinkage estimation of subgroup effects through Dirichlet process priors publication-title: J Biopharm Stat – volume: 21 start-page: 4035 issue: 18 year: 2015 end-page: 4039 article-title: FDA approval: blinatumomab publication-title: Clin Cancer Res – volume: 167 start-page: 926 issue: 10 year: 2013 end-page: 932 article-title: Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007 publication-title: JAMA Pediatr – volume: 17 start-page: 629 issue: 5 year: 2018 end-page: 647 article-title: Propensity score matched augmented controls in randomized clinical trials: a case study publication-title: Pharma Stat – volume: 375 start-page: 2293 issue: 23 year: 2016 end-page: 2297 article-title: Real-world evidence—what is it and what can it tell us publication-title: N Engl J Med – volume: 64 start-page: 595 issue: 2 year: 2008 end-page: 602 article-title: Determining the effective sample size of a parametric prior publication-title: Biometrics – volume: 138 start-page: e20160223 year: 2016 article-title: Discontinuation and nonpublication of randomized clinical trials conducted in children publication-title: Pediatrics – volume: 28 start-page: 4221 year: 2010 article-title: Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study publication-title: J Clin Oncol – volume: 35 start-page: 2117 year: 2016 end-page: 2132 article-title: Evidence, eminence and extrapolation publication-title: Stat Med – volume: 32 start-page: 808 issue: 5 year: 2013 end-page: 821 article-title: A general binomial regression model to estimate standardized risk differences from binary response data publication-title: Stat Med – volume: 104 start-page: 585 issue: suppl 3 year: 1999 end-page: 590 article-title: An update on the therapeutic orphan publication-title: Pediatrics – volume: 70 start-page: 1023 issue: 4 year: 2014 end-page: 1032 article-title: Robust meta-analytic-predictive priors in clinical trials with historical control information publication-title: Biometrics – volume: 7 start-page: 5 issue: 1 year: 2010 end-page: 18 article-title: Summarizing historical information on controls in clinical trials publication-title: Clin Trials – volume: 53 start-page: 154 issue: 1 year: 2019 end-page: 163 article-title: Unique burdens of pediatric clinical trials in Duchenne muscular dystrophy, April 20-21, 2017, Bethesda, Maryland, USA publication-title: Therapeutic Innovation & Regulatory Science – volume: 51 start-page: 360 issue: 3 year: 2017 end-page: 371 article-title: Pediatric medicine development: an overview and comparison of regulatory processes in the European Union and United States publication-title: Therapeutic Innovation & Regulatory Science – start-page: e141 year: 2015 end-page: e147 article-title: Improving clinical trial efficiency: thinking outside the box publication-title: Am Soc Clin Oncol Educ Book – volume: 15 start-page: e1002520 issue: 3 year: 2018 article-title: Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: a cohort study publication-title: PLoS Med – volume: 39 start-page: 276 issue: 2 year: 2012 end-page: 285 article-title: Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease publication-title: J Rheumatol – volume: 61 start-page: 738 issue: 3 year: 2005 end-page: 748 article-title: Combining multiple comparisons and modeling techniques in dose-response studies publication-title: Biometrics – volume: 128 start-page: e1242 issue: 5 year: 2011 end-page: e1249 article-title: Extrapolation of adult data and other data in pediatric drug-development programs publication-title: Pediatrics – volume: 115 start-page: 2514 issue: 11 year: 2009 end-page: 2522 article-title: Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma publication-title: Cancer – volume: 43 start-page: 857 year: 2017 end-page: 860 article-title: Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies publication-title: J Med Ethics – ident: CR45 – ident: CR22 – volume: 28 start-page: 4221 year: 2010 ident: CR28 article-title: Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study publication-title: J Clin Oncol – volume: 61 start-page: 738 issue: 3 year: 2005 end-page: 748 ident: CR29 article-title: Combining multiple comparisons and modeling techniques in dose-response studies publication-title: Biometrics – volume: 7 start-page: 5 issue: 1 year: 2010 end-page: 18 ident: CR33 article-title: Summarizing historical information on controls in clinical trials publication-title: Clin Trials – ident: CR51 – ident: CR12 – volume: 15 start-page: e1002520 issue: 3 year: 2018 ident: CR13 article-title: Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: a cohort study publication-title: PLoS Med – volume: 39 start-page: 276 issue: 2 year: 2012 end-page: 285 ident: CR43 article-title: Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease publication-title: J Rheumatol – ident: CR8 – volume: 172 start-page: 21 year: 2009 end-page: 47 ident: CR23 article-title: Bias modelling in evidence synthesis publication-title: J R Stat Soc Ser A Stat Soc – volume: 115 start-page: 2514 issue: 11 year: 2009 end-page: 2522 ident: CR27 article-title: Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma publication-title: Cancer – ident: CR25 – volume: 17 start-page: 629 issue: 5 year: 2018 end-page: 647 ident: CR38 article-title: Propensity score matched augmented controls in randomized clinical trials: a case study publication-title: Pharma Stat – volume: 167 start-page: 926 issue: 10 year: 2013 end-page: 932 ident: CR57 article-title: Adolescent dosing and labeling since the Food and Drug Administration Amendments Act of 2007 publication-title: JAMA Pediatr – ident: CR21 – ident: CR46 – start-page: 219 year: 2011 end-page: 244 ident: CR18 article-title: Ethical considerations in conducting pediatric research publication-title: Pediatric Clinical Pharmacology – volume: 46 start-page: 33 issue: 1 year: 1990 end-page: 48 ident: CR26 article-title: Continual reassessment method: a practical design for phase 1 clinical trials in cancer publication-title: Biometrics – year: 2006 ident: CR39 publication-title: Uncertain Judgements: Eliciting Experts’ Probabilities – volume: 77 start-page: 1247 year: 2017 end-page: 1249 ident: CR54 article-title: Cerliponase alfa: first global approval publication-title: Drugs – volume: 35 start-page: 2117 year: 2016 end-page: 2132 ident: CR44 article-title: Evidence, eminence and extrapolation publication-title: Stat Med – ident: CR11 – volume: 79 start-page: 593 issue: 3 year: 1992 end-page: 601 ident: CR37 article-title: Bayesian methodology for combining the results from different experiments when the specifications for pooling are uncertain publication-title: Biometrika – volume: 128 start-page: e1242 issue: 5 year: 2011 end-page: e1249 ident: CR19 article-title: Extrapolation of adult data and other data in pediatric drug-development programs publication-title: Pediatrics – volume: 21 start-page: 4035 issue: 18 year: 2015 end-page: 4039 ident: CR56 article-title: FDA approval: blinatumomab publication-title: Clin Cancer Res – volume: 104 start-page: 585 issue: 3 year: 1999 end-page: 590 ident: CR2 article-title: An update on the therapeutic orphan publication-title: Pediatrics – ident: CR5 – volume: 134 start-page: e512 issue: 2 year: 2014 end-page: e518 ident: CR15 article-title: Impact of pediatric exclusivity on drug labeling and demonstrations of efficacy publication-title: Pediatrics – volume: 32 start-page: 808 issue: 5 year: 2013 end-page: 821 ident: CR48 article-title: A general binomial regression model to estimate standardized risk differences from binary response data publication-title: Stat Med – volume: 138 start-page: e20160223 year: 2016 ident: CR14 article-title: Discontinuation and nonpublication of randomized clinical trials conducted in children publication-title: Pediatrics – volume: 43 start-page: 857 year: 2017 end-page: 860 ident: CR30 article-title: Meeting the goal of concurrent adolescent and adult licensure of HIV prevention and treatment strategies publication-title: J Med Ethics – ident: CR47 – volume: 51 start-page: 360 issue: 3 year: 2017 end-page: 371 ident: CR9 article-title: Pediatric medicine development: an overview and comparison of regulatory processes in the European Union and United States publication-title: Therapeutic Innovation & Regulatory Science – volume: 64 start-page: 595 issue: 2 year: 2008 end-page: 602 ident: CR36 article-title: Determining the effective sample size of a parametric prior publication-title: Biometrics – volume: 12 start-page: 1583 issue: 3 year: 2018 end-page: 1604 ident: CR34 article-title: Bayesian aggregation of average data: an application in drug development publication-title: Ann Appl Stat – ident: CR10 – year: 2004 ident: CR4 publication-title: Ethical Conduct of Clinical Research Involving Children – ident: CR6 – volume: 53 start-page: 154 issue: 1 year: 2019 end-page: 163 ident: CR16 article-title: Unique burdens of pediatric clinical trials in Duchenne muscular dystrophy, April 20-21, 2017, Bethesda, Maryland, USA publication-title: Therapeutic Innovation & Regulatory Science – start-page: 350 year: 2009 ident: CR53 publication-title: Causality: Models, Reasoning, and Inference – volume: 16 start-page: 232 issue: 4 year: 2017 end-page: 249 ident: CR31 article-title: Statistical modeling for Bayesian extrapolation of adult clinical trial information in pediatric drug evaluation publication-title: Pharm Stat – volume: 26 start-page: 1040 issue: 6 year: 2016 end-page: 1055 ident: CR49 article-title: Flexible shrinkage estimation of subgroup effects through Dirichlet process priors publication-title: J Biopharm Stat – ident: CR40 – start-page: 411 year: 1975 end-page: 421 ident: CR1 article-title: Pragmatic assessment of medicines available for young children and pregnant or breast-feeding women publication-title: Basic and Therapeutic Aspects of Perinatal Pharmacology – volume: 375 start-page: 2293 issue: 23 year: 2016 end-page: 2297 ident: CR50 article-title: Real-world evidence—what is it and what can it tell us publication-title: N Engl J Med – ident: CR3 – volume: 38 start-page: 462 issue: 3 year: 2011 end-page: 469 ident: CR42 article-title: Effect of warfarin on survival in scleroderma-associated pulmonary arterial hypertension (SSc-PAH) and idiopathic PAH. Belief elicitation for Bayesian priors publication-title: J Rheumatol – ident: CR52 – ident: CR17 – volume: 70 start-page: 1023 issue: 4 year: 2014 end-page: 1032 ident: CR35 article-title: Robust meta-analytic-predictive priors in clinical trials with historical control information publication-title: Biometrics – ident: CR55 – ident: CR7 – volume: 13 start-page: 41 issue: 1 year: 2014 end-page: 54 ident: CR32 article-title: Use of historical control data for assessing treatment effects in clinical trials publication-title: Pharm Stat – ident: CR24 – volume: 78 start-page: 898 issue: 4 year: 2014 end-page: 907 ident: CR41 article-title: Bridging the gap: a review of dose investigations in paediatric investigation plans publication-title: Br J Clin Pharmacol – ident: CR20 – volume: 15 start-page: e1002520 issue: 3 year: 2018 ident: 5305567_CR13 publication-title: PLoS Med doi: 10.1371/journal.pmed.1002520 – volume: 7 start-page: 5 issue: 1 year: 2010 ident: 5305567_CR33 publication-title: Clin Trials doi: 10.1177/1740774509356002 – volume: 46 start-page: 33 issue: 1 year: 1990 ident: 5305567_CR26 publication-title: Biometrics doi: 10.2307/2531628 – volume: 64 start-page: 595 issue: 2 year: 2008 ident: 5305567_CR36 publication-title: Biometrics doi: 10.1111/j.1541-0420.2007.00888.x – ident: 5305567_CR45 – volume: 79 start-page: 593 issue: 3 year: 1992 ident: 5305567_CR37 publication-title: Biometrika doi: 10.1093/biomet/79.3.593 – ident: 5305567_CR22 – volume: 16 start-page: 232 issue: 4 year: 2017 ident: 5305567_CR31 publication-title: Pharm Stat doi: 10.1002/pst.1807 – volume: 78 start-page: 898 issue: 4 year: 2014 ident: 5305567_CR41 publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.12402 – volume: 77 start-page: 1247 year: 2017 ident: 5305567_CR54 publication-title: Drugs doi: 10.1007/s40265-017-0771-8 – ident: 5305567_CR8 – volume: 32 start-page: 808 issue: 5 year: 2013 ident: 5305567_CR48 publication-title: Stat Med doi: 10.1002/sim.5553 – ident: 5305567_CR12 – volume: 128 start-page: e1242 issue: 5 year: 2011 ident: 5305567_CR19 publication-title: Pediatrics doi: 10.1542/peds.2010-3487 – ident: 5305567_CR21 – volume: 38 start-page: 462 issue: 3 year: 2011 ident: 5305567_CR42 publication-title: J Rheumatol doi: 10.3899/jrheum.100632 – volume: 104 start-page: 585 issue: 3 year: 1999 ident: 5305567_CR2 publication-title: Pediatrics doi: 10.1542/peds.104.S3.585 – ident: 5305567_CR5 – ident: 5305567_CR25 – volume: 21 start-page: 4035 issue: 18 year: 2015 ident: 5305567_CR56 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-15-0612 – ident: 5305567_CR11 – volume: 375 start-page: 2293 issue: 23 year: 2016 ident: 5305567_CR50 publication-title: N Engl J Med doi: 10.1056/NEJMsb1609216 – ident: 5305567_CR20 – ident: 5305567_CR46 doi: 10.14694/EdBook_AM.2015.35.e141 – volume: 134 start-page: e512 issue: 2 year: 2014 ident: 5305567_CR15 publication-title: Pediatrics doi: 10.1542/peds.2013-2987 – ident: 5305567_CR24 – volume: 70 start-page: 1023 issue: 4 year: 2014 ident: 5305567_CR35 publication-title: Biometrics doi: 10.1111/biom.12242 – start-page: 411 volume-title: Basic and Therapeutic Aspects of Perinatal Pharmacology year: 1975 ident: 5305567_CR1 – volume: 167 start-page: 926 issue: 10 year: 2013 ident: 5305567_CR57 publication-title: JAMA Pediatr doi: 10.1001/jamapediatrics.2013.465 – volume: 12 start-page: 1583 issue: 3 year: 2018 ident: 5305567_CR34 publication-title: Ann Appl Stat doi: 10.1214/17-AOAS1122 – volume: 115 start-page: 2514 issue: 11 year: 2009 ident: 5305567_CR27 publication-title: Cancer doi: 10.1002/cncr.24286 – volume: 138 start-page: e20160223 year: 2016 ident: 5305567_CR14 publication-title: Pediatrics doi: 10.1542/peds.2016-0223 – ident: 5305567_CR6 – ident: 5305567_CR52 – volume: 17 start-page: 629 issue: 5 year: 2018 ident: 5305567_CR38 publication-title: Pharma Stat doi: 10.1002/pst.1879 – volume: 39 start-page: 276 issue: 2 year: 2012 ident: 5305567_CR43 publication-title: J Rheumatol doi: 10.3899/jrheum.110765 – ident: 5305567_CR47 – ident: 5305567_CR10 – volume: 13 start-page: 41 issue: 1 year: 2014 ident: 5305567_CR32 publication-title: Pharm Stat doi: 10.1002/pst.1589 – ident: 5305567_CR17 – ident: 5305567_CR40 – volume: 43 start-page: 857 year: 2017 ident: 5305567_CR30 publication-title: J Med Ethics doi: 10.1136/medethics-2016-103600 – start-page: 219 volume-title: Pediatric Clinical Pharmacology year: 2011 ident: 5305567_CR18 doi: 10.1007/978-3-642-20195-0_11 – volume-title: Uncertain Judgements: Eliciting Experts’ Probabilities year: 2006 ident: 5305567_CR39 doi: 10.1002/0470033312 – start-page: 350 volume-title: Causality: Models, Reasoning, and Inference year: 2009 ident: 5305567_CR53 doi: 10.1017/CBO9780511803161 – volume-title: Ethical Conduct of Clinical Research Involving Children year: 2004 ident: 5305567_CR4 – ident: 5305567_CR3 – volume: 172 start-page: 21 year: 2009 ident: 5305567_CR23 publication-title: J R Stat Soc Ser A Stat Soc doi: 10.1111/j.1467-985X.2008.00547.x – ident: 5305567_CR51 – volume: 51 start-page: 360 issue: 3 year: 2017 ident: 5305567_CR9 publication-title: Therapeutic Innovation & Regulatory Science doi: 10.1177/2168479017696265 – volume: 53 start-page: 154 issue: 1 year: 2019 ident: 5305567_CR16 publication-title: Therapeutic Innovation & Regulatory Science doi: 10.1177/2168479018764650 – volume: 26 start-page: 1040 issue: 6 year: 2016 ident: 5305567_CR49 publication-title: J Biopharm Stat doi: 10.1080/10543406.2016.1226327 – ident: 5305567_CR55 – ident: 5305567_CR7 – volume: 28 start-page: 4221 year: 2010 ident: 5305567_CR28 publication-title: J Clin Oncol doi: 10.1200/JCO.2010.28.4687 – volume: 35 start-page: 2117 year: 2016 ident: 5305567_CR44 publication-title: Stat Med doi: 10.1002/sim.6865 – volume: 61 start-page: 738 issue: 3 year: 2005 ident: 5305567_CR29 publication-title: Biometrics doi: 10.1111/j.1541-0420.2005.00344.x |
| SSID | ssj0000985728 |
| Score | 2.187765 |
| Snippet | The conduct of pediatric clinical trials is legally required, monitored, and encouraged in major geographic areas such as the United States and Europe.... |
| SourceID | proquest pubmed crossref springer sage |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 567 |
| SubjectTerms | Adolescent Bayes Theorem Child Children Clinical trials Clinical Trials as Topic - methods Deep Learning Drug development Drug Development - methods Drug Safety and Pharmacovigilance Ethical standards Extrapolation Humans Mathematical analysis Pediatrics Pharmacotherapy Pharmacy Research Design Special Section: Pediatric Therapeutic Development: Original Article United States |
| Title | Incorporating Innovative Techniques Toward Extrapolation and Efficient Pediatric Drug Development |
| URI | https://journals.sagepub.com/doi/full/10.1177/2168479019842541 https://link.springer.com/article/10.1177/2168479019842541 https://www.ncbi.nlm.nih.gov/pubmed/31084211 https://www.proquest.com/docview/2279263796 https://www.proquest.com/docview/2232012691 |
| Volume | 53 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVK98ILYnwWBjISqgRdtnw4Tvq4QasBpUwilfoWOY4zVRpN1aYT5ZFfznXsOOk6YPASVYnrWLnH9rXv9TkIvRZZwJid-RZJU2KRgHMrTD0p9yIRQz3Hz-RC8fOYnk3Ix6k_bbV-NrKW1kVyxH_ceK7kf6wK98Cu8pTsP1jWVAo34DfYF65gYbjeysYfJAllSUSs4v5K4PRKqA1zycy66kVlXmxv8L1YskWuMt_KiMGgJI-QqQBGrqP3frm-aOYRNV3XqD6p1ZsZLdUSOkslaC_D9XpGNWk97Bu7zK2vM7CiEmOrlHUbW-cLfeprNFuZSeJTXmUUsKJgGxiTGjEkLRYmYAouKnjrnQunTs3SA5zrULmZqeSHj8QN9_QIreiENRL9xnDrKymP3WmgDETLukgADk9fxhoVv9Y24_b4SzycjEZxNJhGd9CeC0sNt432Toanp2OzU2f3Qz8oRXpN4-p49_H1l2z7NzuLFp0wuBN3L92Z6D66p9ch-ESBah-1xPwB6p4rIvPNIW5Ye3WIu_i8pjjfPERsC3m4Rh6ukYcV8vAW8jAgDxvkYYM8LJGHG8h7hCbDQfTuzNJiHRYndlBYGXRqGiROZgtGmBAu-MVpGBBhEyekPM1STjMuw_K2zUnKiEg8WIrzQJ5XZeA1P0bteT4XTxF2Epo6lIL3COWhvrDPuBPaIiUi8IknOui4-sQx10z2UlDlMnY0ef11o3TQG_OPhWJx-UPZg8pqse7rq7jk2aRe0Kcd9Mo8hpFYhtfYXORrWcYDlLu0D1U8UdY2L4NFFNTuwJOuNH9d8e9b8bYCyN8LP7tFm56ju3UfPEDtYrkWL8CfLpKXGvC_AOFYx90 |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incorporating+Innovative+Techniques+Toward+Extrapolation+and+Efficient+Pediatric+Drug+Development&rft.jtitle=Therapeutic+innovation+%26+regulatory+science&rft.au=Gamalo-Siebers%2C+Margaret&rft.au=Hampson%2C+Lisa&rft.au=Kordy%2C+Kattayoun&rft.au=Weber%2C+Sebastian&rft.date=2019-09-01&rft.issn=2168-4804&rft.eissn=2168-4804&rft.volume=53&rft.issue=5&rft.spage=567&rft_id=info:doi/10.1177%2F2168479019842541&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-4790&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-4790&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-4790&client=summon |